Cognition Disorders  >>  verubecestat (MK-8931)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
verubecestat (MK-8931) / Merck (MSD)
NCT02910739: An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016)

Completed
1
16
NA
MK-8931, Verubecestat
Merck Sharp & Dohme LLC
Amnestic Mild Cognitive Impairment, Alzheimer's Disease, Prodromal Alzheimer's Disease
04/17
04/17

Download Options